OCUL - Company ID 0001393434
The table below shows OCULAR THERAPEUTIX, INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $737.06M | $392.10M | $195.81M | $102.30M | $164.16M | $228.06M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $30.65M | $32.39M | $26.18M | $21.32M | $21.14M | $12.25M |
| Inventory | $3.56M | $3.04M | $2.31M | $1.97M | $1.25M | $1.20M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $782.13M |
| $440.99M |
| $232.24M |
| $129.63M |
| $191.30M |
| $246.16M |
| Property, plant & equipment | $19.68M | $9.39M | $11.74M | $9.86M | $6.96M | $8.10M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $808.06M | $457.94M | $252.06M | $149.29M | $204.89M | $261.86M |
| Accounts payable | $4.15M | $4.18M | $4.39M | $5.12M | $4.59M | $2.71M |
| Total current liabilities | $50.81M | $41.35M | $34.90M | $31.39M | $26.34M | $26.66M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $153.75M | $142.59M | $160.93M | $113.91M | $116.89M | $185.77M |
| Retained earnings | -$1.16B | -$891.08M | -$697.58M | -$616.84M | -$545.80M | -$539.25M |
| Total equity | $654.31M | $315.34M | $91.13M | $35.38M | $88.00M | $76.09M |